The microbiological examination of sputum in the context of cystic fibrosis has experienced a number of major upheavals in recent years.
Clinicians and microbiologists are mainly confronted with the qualitative and quantitative isolation of pathogenic major said, Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia, or Stenotrophomas maltophilia and Aspergillus spp. Despite the isolation of these pathogens in the context of cystic fibrosis, and inherent antimicrobial treatment during exacerbation, patients with cystic fibrosis, may present responses / from very different treatment. The major reasons for these varying answers seem to lie in the isolation of respiratory viruses and other bacteria; intracellular bacteria, mycobacteria whose rapidly growing mycobacteria and members of the oropharyngeal flora as streptococci, or anaerobic bacteria. The role that each plays of them, individually or in association with other well-known pathogens, currently a key subject of debate in the understanding of pulmonary microbial infections and the occurrence of exacerbations in these patients.
Full conference title:
- RICAI 31st (2011)